Today: 29 April 2026
Browse Category

NSE:HZL 18 December 2025 - 17 January 2026

Silver Price Breaks $70 on Dec 23, 2025 — and Hindustan Zinc Becomes the Stock Market’s Silver Proxy

Silver Price Breaks $70 on Dec 23, 2025 — and Hindustan Zinc Becomes the Stock Market’s Silver Proxy

Global silver prices broke above $70 per ounce for the first time on December 23, 2025, triggering record highs on India’s MCX, where silver spiked to nearly ₹2,17,800 per kg. Hindustan Zinc shares climbed over 3% as investors bet on higher earnings from the company’s major silver production. The surge was fueled by strong industrial demand, tightening supply, and expectations of U.S. rate cuts.
24 December 2025
·
Vedanta Demerger Update Dec 22, 2025: NCLT Approval, 1:1 Share Entitlement, Dividend Signals and Silver Rally at Hindustan Zinc

Vedanta Demerger Update Dec 22, 2025: NCLT Approval, 1:1 Share Entitlement, Dividend Signals and Silver Rally at Hindustan Zinc

India’s National Company Law Tribunal has approved Vedanta Ltd’s revised demerger scheme, dismissing key objections and allowing the company to proceed with splitting into multiple listed entities. The order requires Vedanta to meet compliance steps within two months before the demerger takes effect. Hindustan Zinc shares hit record highs after a surge in silver prices, drawing investor focus to the group’s restructuring.
22 December 2025
·
Vedanta Ltd Stock Hits Fresh Highs After NCLT Demerger Nod: Latest News, Broker Targets, Dividend Outlook and Key Risks (18 Dec 2025)

Vedanta Ltd Stock Hits Fresh Highs After NCLT Demerger Nod: Latest News, Broker Targets, Dividend Outlook and Key Risks (18 Dec 2025)

Vedanta Ltd shares hovered near a record ₹580 after the National Company Law Tribunal approved its demerger plan, disclosed December 16. The split will create five listed entities, but approval for the merchant power business remains pending. Brokerages raised targets amid debate over debt and governance. Investors await the record date for share entitlements.
18 December 2025
····

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:57 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Go toTop